3Rosenberg J C, Jukuruga D, Williams T. HLA and solid organ transplantation: a review of the literature of the 90s. In: terasaki PI, Gjertson DW. Eds. HLA 1997. Los Angeles: Press of the University of California, 1998. 7-38.
4Cho Y W,Cecka J M. Terasaki HLA matching effect:better survival rates and graft quality. In: Terasaki PI, Cecka JM.. eds. Clinical transplant 1994. Los Angeles: UCLA Press, 1994. 435-439.
5Opelz G. HLA Compatibility and kidney grafts from unrelated live donors. Transplant Proc,1998, 30: 704.
6Petersen P, Scheeberger S, Schleibner S, et al. HLA matching and short/long-term outcome of cadaverice renal allografts: Large single centre asta confirm the multicentre analyses. Transplant Proc, 1995,27 (1): 658.
7Wujciak T, Opelz G. Evaluation of HLA matching for CREG antigens in Europe. Transplantation, 1999 ,27;68(8): 1097- 1099.
8Taylor C J, Dyer P A. Maximizing the benefits of HLA matching for renal transplantation: alleles, specificities,cregs, epitopes, or residues. Transplantation 1999,27;68(8): 1093- 1094.
9Sijpkens Y W, Doxiadis I I, De Fijter J W, et al. Sharing cross-reactive groups of MHC class Ⅰ improves long-term graft survival. : Kidney Int, 1999 , 56 (5):920-1927.
10Stobbe I, van der Meer Prins E M, de Lange P, et al.Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys. Transplantation, 2000, 70(1): 157-161.
